- Home
- ABEO vs DSP Comparison
ABEO vs DSP Comparison
Compare ABEO & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- DSP
- Stock Information
- Founded
- ABEO 1974
- DSP 1999
- Country
- ABEO United States
- DSP United States
- Employees
- ABEO N/A
- DSP N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- DSP EDP Services
- Sector
- ABEO Health Care
- DSP Technology
- Exchange
- ABEO Nasdaq
- DSP Nasdaq
- Market Cap
- ABEO 256.9M
- DSP 220.3M
- IPO Year
- ABEO 1980
- DSP 2021
- Fundamental
- Price
- ABEO $6.24
- DSP $13.79
- Analyst Decision
- ABEO Strong Buy
- DSP Strong Buy
- Analyst Count
- ABEO 5
- DSP 8
- Target Price
- ABEO $17.80
- DSP $21.75
- AVG Volume (30 Days)
- ABEO 1.7M
- DSP 239.1K
- Earning Date
- ABEO 05-15-2025
- DSP 05-06-2025
- Dividend Yield
- ABEO N/A
- DSP N/A
- EPS Growth
- ABEO N/A
- DSP N/A
- EPS
- ABEO N/A
- DSP 0.13
- Revenue
- ABEO N/A
- DSP $306,484,000.00
- Revenue This Year
- ABEO N/A
- DSP $19.27
- Revenue Next Year
- ABEO $383.07
- DSP $14.55
- P/E Ratio
- ABEO N/A
- DSP $106.36
- Revenue Growth
- ABEO N/A
- DSP 30.64
- 52 Week Low
- ABEO $3.93
- DSP $8.70
- 52 Week High
- ABEO $7.32
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- ABEO 56.57
- DSP 45.58
- Support Level
- ABEO $5.93
- DSP $13.46
- Resistance Level
- ABEO $7.17
- DSP $14.72
- Average True Range (ATR)
- ABEO 0.44
- DSP 0.66
- MACD
- ABEO -0.01
- DSP -0.16
- Stochastic Oscillator
- ABEO 50.00
- DSP 11.83
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.